Blood News: Breaking Blood News, Comments and Articles. - Page: 5

Mayo Clinic first in U.S. to test stem cells in pediatric congenital heart disease patients

Mayo Clinic has announced the first U.S. stem cell clinical trial for pediatric congenital heart disease. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS), a...

Sticky cells, blood vessels and cancer – the paradox of Claudin-14

How do our bodies form new blood vessels? This is a key question in cancer research, as tumours need to develop a new blood supply to grow. Last summer, Dr Marianne Baker finished her Cancer Research UK-funded PhD in the … Continue reading U...

Lineage Therapeutics Markets Authorized Generic Epinephrine Auto-Injector

HORSHAM, Pa., June 14, 2013 /PRNewswire/ -- Lineage Therapeutics Inc. has announced the US launch of its generic epinephrine injection, USP auto-injector, the authorized generic of Adrenaclick® by Amedra Pharmaceuticals LLC, for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The product is available as a two-pack...

Amedra Pharmaceuticals Markets Adrenaclick® Auto-Injector

HORSHAM, Pa., June 14, 2013 /PRNewswire/ -- Amedra Pharmaceuticals LLC has announced re-launch of Adrenaclick®, a single-dose epinephrine auto-injector, for the emergency treatment of life threatening allergic reactions in people who are at risk for or have a history of anaphylaxis.  Adrenaclick® will be available as a two-pack carton in both 0.15 mg and 0.30 mg strengths....

Google+ Hangout Discussion Today With Prostate Specialist, Mark Scholz, MD and Wirebuzz.com for International Men's Health Month

MARINA DEL REY, Calif., June 14, 2013 /PRNewswire/ -- Google, in partnership with WireBuzz.com and Prevention.com, will feature a series of health-centered Google+ Hangouts for International Men's Health Month. The live discussions will build awareness around men's health issues including diet and exercise, cancer, sexual health and more. Using Google+ Hangouts, participants from all over th...

Stem Cells May Help Some With Avascular Necrosis (AVN)

TAMPA, Fla., June 14, 2013 /PRNewswire/ -- Stem cells have long been touted as the next big thing. Well just maybe, it is here.  According to Dr. Dennis Lox, some patients with a disorder of the bone called avascular necrosis (AVN), have turned to stem cell therapy for aid. Avascular necrosis (AVN) also referred to as osteonecrosis or ischemic necrosis, is a condition in which the blood...

HHS Secretary Kathleen Sebelius statement on World Blood Donor Day

Today, the Department of Health and Human Services is pleased to recognize World Blood Donor Day and the unique life-saving role that blood donors play in communities in the United States and around the world. This year’s slogan, “Give the gift of life: donate blood,” reminds us that many in this world do not have timely access to safe blood...

Nine recent publications on feeding of GM maize Bt MON810 to pigs

Effects of feeding Bt MON810 maize to sows during first gestation and lactation on maternal and offspring health indicators.Walsh MC, Buzoianu SG, Gardiner GE, Rea MC, O'Donovan O, Ross RP, Lawlor PG.Teagasc, Pig Development Department, Animal and Grassland Research and InnovationCentre, Moorepark, Fermoy, County Cork, Republic of Ireland.A total of twen

DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits

Kansas City, MO (PRWEB) June 14, 2013 The birth control safety advocates at DrugRisk.com are announcing new information on the site for women who have used the vaginal ring contraceptive NuvaRing. A federal panel recently ruled that five patients...

New Yaz, Yasmin Blood-Clotting Lawsuits Allegations Update: Resource4thePeople Reports Health Canada Reports 23 Deaths Among Contraceptive Users

San Diego, CA (PRWEB) June 14, 2013 http://www.resource4thepeople.com/defectivedrugs/yasmin.html Resource4thePeople is updating consumers interested in birth control litigation today with news from Canada where national media are reporting th...

Edison Investment - Epigenomics - Going head-to-head with Exact

Acceptance of its PMA application and notification of priority review status puts Epigenomics’ bood-based Epi proColon on track for approval in Q413. Meanwhile, rival Exact Sciences is expected to file a PMA application for its stool-based Cologuard test shortly. The disparity in the market’s enterprise valuations of the two companies ($27m vs $750m) suggests that investors believe E...

WHO Pleads for Voluntary Blood Donors Amid Low Supply -- Voice of America

Ahead of World Blood Donor Day, Lisa Schlein reports on safe blood supply need and the key role of voluntary blood donors. "The World Health Organization [WHO] warns there is a global shortage of safe blood...[and] is appealing for more voluntary blood donors...[as] millions of patients requiring life-saving transfusions do not have timely access to safe blood. In low- and middle-income countries,...

Pharmacyclics' Recent Sell-Off Was Wrong: Here's Why We're Involved

ByPropThink:By Ivan DeryuginAlthough Infinity Pharmaceuticals' (INFI) post-ASCO selloff, which we discussed on Monday, was perhaps the most prominent ASCO demolition, it wasn't the only unwarranted decline. Shares of segment-leading Pharmacyclics (PCYC) have also fallen in the wake of the company's ASCO presentations, from nearly $92 to $83. Shares have since rebounded to almost $88, but we're exp...

New Long-Term Data Published in Circulation Reinforce Safety Profile of Pradaxa® (dabigatran etexilate mesylate)

RIDGEFIELD, Conn., June 14, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from the RELY-ABLE® trial, a long-term extension of the pivotal RE-LY® study of Pradaxa® (dabigatran etexilate mesylate) capsules in patients with non-valvular atrial fibrillation (NVAF). PRADAXA is the first treatment among the new generation of oral anticoagulan...

EHA 2013: Addition of obinutuzumab or rituximab to chlorambucil improves outcomes for chronic lymphocytic leukaemia and co-existing medical conditions

Dr Valentin Goede presented promising outcomes for elderly CLL patients at the 18th Congress of the European Hematology Association in Stockholm. CLL is the most common leukaemia in the western world. Many CLL patients are elderly and have comorbid...

EHA 2013: Targeting the JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms

Dr Ross Levine presented results from a study on targeting the JAK-STAT pathway in myeloproliferative neoplasms at the EHA 2013. Myeloproliferative neoplasms (MPN) are clonal blood disorders characterised by excessive production of mature blood...

Texas Children's Hospital opens first pediatric Stone Clinic in Texas

HOUSTON, June 14, 2013 /PRNewswire-USNewswire/ -- Texas Children's Hospital announced a new, first of its kind in Texas, pediatric Stone Clinic which will provide comprehensive care for children and adolescents with kidney stones. The clinic will be comprised of a multidisciplinary team of specialists that will evaluate, diagnose and treat children who have previously had kidney stones, as well as...

Use of G-CSF biosimilars for reduction of fever

The American Society of Hematology, the British Society of Haematology, the European Society of Hematology and the European Group of Bone Marrow Transplantation all recommend the use of granulocyte colony-stimulating factor (G-CSF) after transplant i...

EHA 2013: Mini-hormone fights iron

Dr Elizabeta Nemeth presents findings of a study in patients with iron overload disorders that will contribute to the design of a potential new treatment at the 18th Congress of the European Hematology Association in Stockholm. Iron overload commonl...

Codman Neuro Obtains CE Mark For Enhanced REVIVE SE™ Thrombectomy Device

PARIS, June 14, 2013 /PRNewswire/ -- Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, has obtained CE marking for REVIVE SE, a next-generation self-expanding clot removal device for use in treating acute ischemic stroke, the company announced today at the Live Interventional Neuroradiology & Neurosurgery Course (LINNC) in Paris. The REVIVE SE device is a self-expa...

PAHO/WHO Urges Countries Of The Americas To Work Toward 100% Voluntary Altruistic Blood Donation

In Latin America and the Caribbean, only 41% of blood supplies are obtained through voluntary altruistic blood donation, the safest way to collect blood, according to the Pan American Health Organization/World Health Organization (PAHO/WHO). Today on...

Volunteer Work Lowers Hypertension Risk For Aging Adults

April Flowers for redOrbit.com - Your Universe Online The social value of volunteering has been known for a long time, but a new study from Carnegie Mellon University shows that helping others can help your health as well. The study reveals that older adults who volunteer for a minimum of 200 hours per year reduce their risk of hypertension, or high blood pressure, by 40 percent. According to th...

Minihormon bekämpft Eisen

STOCKHOLM , June 14, 2013 /- Dr. Elizabeth Nemeth wird auf dem 18. Kongress der European Hematology Association in Stockholm Ergebnisse einer Studie an Patienten mit Eisenüberladungserkrankungen präsentieren, die zum Entwurf einer m...

Une mini-hormone pour contrer le fer

STOCKHOLM , June 14, 2013 /- Le docteur Elizabeta Nemeth présentera lors du 18 e  congrès de l'Association européenne d'hématologie (EHA - European Hematology Association) à Stockholm les conclusions d'une é...

Research: Older adults who volunteer for work decrease their risk of hypertension

New research from Carnegie Mellon University shows that older adults who volunteer for at least 200 hours per year decrease their risk of hypertension, or high blood pressure, by 40 percent.